Cargando…
Th2 cells inhibit growth of colon and pancreas cancers by promoting anti-tumorigenic responses from macrophages and eosinophils
BACKGROUND: Immunotherapy of gastrointestinal cancers is challenging; however, several lines of evidence suggest that adoptive transfer of stimulated or modified immune cells support not only protective role of immune cells in tumor microenvironment, but actively participate in the elimination of ca...
Autores principales: | Jacenik, Damian, Karagiannidis, Ioannis, Beswick, Ellen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902541/ https://www.ncbi.nlm.nih.gov/pubmed/36376448 http://dx.doi.org/10.1038/s41416-022-02056-2 |
Ejemplares similares
-
G-CSF and G-CSFR Induce a Pro-Tumorigenic Macrophage Phenotype to Promote Colon and Pancreas Tumor Growth
por: Karagiannidis, Ioannis, et al.
Publicado: (2020) -
MK2 drives progression of pancreas and colon cancers by suppressing CD8(+) T cell cytotoxic function and is a potential immunotherapy target
por: Jacenik, Damian, et al.
Publicado: (2023) -
G-CSF and G-CSFR Modulate CD4 and CD8 T Cell Responses to Promote Colon Tumor Growth and Are Potential Therapeutic Targets
por: Karagiannidis, Ioannis, et al.
Publicado: (2020) -
MK2 Promotes the Development and Progression of Pancreatic Neuroendocrine Tumors Mediated by Macrophages and Metabolomic Factors
por: Jacenik, Damian, et al.
Publicado: (2022) -
G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis
por: Jacenik, Damian, et al.
Publicado: (2019)